Intellia Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Recent Company Progress

Go back to Intellia Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Recent Company Progress
(NASDAQ: NTLA) Delayed: 12.14 -0.12 (0.98%)
Previous Close $12.26    52 Week High $30.40 
Open $12.16    52 Week Low $11.86 
Day High $12.47    P/E N/A 
Day Low $11.87    EPS $0.00 
Volume 8,626,250